Work

Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections

Year: 2018

Type: article

Source: International Journal of Antimicrobial Agents

DOI: 10.1016/j.ijantimicag.2018.05.012

Authors: David B. Huang, G. Ralph Corey, Thomas L. Holland, Thomas Lodise, William O'Riordan, Mark H. Wilcox, Thomas M. File, Matthew Dryden, Barbara Balser, Eve Desplats, Antoni Torres

Institutions: Motif BioSciences (United States), Rutgers New Jersey Medical School, Duke Medical Center, Albany College of Pharmacy and Health Sciences, University of Leeds, Leeds Teaching Hospitals NHS Trust, Summa Health System, Hampshire Hospitals NHS Foundation Trust, Veristat, LLC (United States), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Hospital Clínic de Barcelona, Universitat de Barcelona

Language: English

Topic: Antimicrobial Resistance in Staphylococcus

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2804406807

FWCI: 2.078

Cites: 16

Cited by: 18

Related to: 10